Document Classification

Section Type: RESULTS

Text: Pioglitazone-treated patients were found to have statistically significantly larger decreases in mean CRP levels (-0. 4 mg/dL) compared to those treated with metformin (-0. 2 mg/dL) (P = 0. 04), as well as greater reductions in levels of mean fasting plasma glucose (-27 vs. -9 mg/dL ; P = 0. 01), serum insulin (-2 vs. -1. 9 mU/L ; P = 0. 014), homeostatic model assessment (HOMA) (-1. 2 vs. -0. 9 ; P = 0. 015), and E-selectin (-12. 4 vs. +3. 4 g/mL ; P = 0. 01).